What is a common initial management strategy for congestive heart failure with reduced ejection fraction?

• A. Calcium Channel Blocker Therapy
• B. Diuretic Monotherapy
• C. ACE inhibitor therapy (or ARB) with beta-blocker as tolerated
• D. Nitrate therapy with ACE inhibitors

Answer: (C)

In heart failure with reduced ejection fraction, starting disease-modifying therapy that has been shown to improve survival is key. An ACE inhibitor (or an ARB if ACE inhibitors aren’t tolerated) together with a beta-blocker, used as tolerated, is the standard initial strategy. This combination targets the harmful neurohormonal activation that drives disease progression, lowers afterload, and helps prevent adverse remodeling of the heart. It’s important to introduce these medications once the patient’s volume status and blood pressure are stable, with monitoring of kidney function and potassium levels.

Diuretics play a crucial role for symptom relief, especially with congestion, but using diuretics alone does not reduce mortality. Calcium channel blockers are not typically started for systolic heart failure because they don’t improve survival and can worsen pump function in reduced EF. Nitrate therapy with ACE inhibitors isn’t the standard initial approach for all patients, though specific combinations may be used in certain situations; the cornerstone for initial management remains ACE inhibitors (or ARBs) with beta-blockers.